Physician profile
Vigen Darian
NPI 1598828113
$4,888.49
in general payments reported to CMS, 2019-2025
22 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $663 · 2021: $484 · 2022: $793 · 2023: $924 · 2024: $700 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,642.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $860.32 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Axogen | $555.91 | 2020-2025 | Avance Nerve Graft |
| Musculoskeletal Transplant Foundation INC. | $488.31 | 2022-2023 | |
| Aerin Medical INC. | $362.06 | 2022-2024 | |
| Avita Medical Americas, LLC | $280.49 | 2024-2025 | Cohealyx, Recell, Permeaderm |
| Baxter Healthcare | $251.20 | 2021 | |
| Mentor Worldwide LLC | $229.73 | 2019-2021 | |
| Acera Surgical, INC. | $160.21 | 2025 | Restrata Wound Matrix |
| Kerecis Limited | $153.03 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $148.82 | 2024 | Grafix Pl, Stravix |
| Abbvie INC. | $147.20 | 2025 | |
| Polynovo North America LLC | $141.17 | 2024 | Novosorb Btm |
| Tela Bio, INC. | $136.08 | 2020 | |
| Stryker Corporation | $125.02 | 2020 | |
| Depuy Synthes Sales INC. | $123.75 | 2023 | Trumatch |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $122.93 | 2025 | Zynrelef |
| Sientra, INC. | $120.89 | 2022 | |
| Polarityte, INC. | $120.87 | 2019 | |
| Allergan, INC. | $116.20 | 2022 | |
| Checkpoint Surgical, INC | $110.86 | 2021 | |
| Tei Biosciences INC | $78.45 | 2019 | |
| Ethicon US, LLC | $54.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vigen Darian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.